| DTB editors say drug’s maker must provide more evidence of clinical and cost effectiveness Related items from OnMedica Alcohol and the nervous system Government urged to stress dangers of even moderate drinking High alcohol intake link to poorer female fertility Exercise might partly compensate for drinking alcohol The medicine price debate |
Thursday, 8 September 2016
Experts call on regulators to revisit nalmefene decision
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment